Literature DB >> 23274881

Drug discovery from marine microbes.

William H Gerwick1, Amanda M Fenner.   

Abstract

The marine environment has been a source of more than 20,000 inspirational natural products discovered over the past 50 years. From these efforts, 9 approved drugs and 12 current clinical trial agents have been discovered, either as natural products or as molecules inspired from the natural product structure. To a significant degree, these have come from collections of marine invertebrates largely obtained from shallow-water tropical ecosystems. However, there is a growing recognition that marine invertebrates are oftentimes populated with enormous quantities of "associated" or symbiotic microorganisms and that microorganisms are the true metabolic sources of these most valuable of marine natural products. Also, because of the inherently multidisciplinary nature of this field, a high degree of innovation is characteristic of marine natural product drug discovery efforts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23274881      PMCID: PMC3640700          DOI: 10.1007/s00248-012-0169-9

Source DB:  PubMed          Journal:  Microb Ecol        ISSN: 0095-3628            Impact factor:   4.552


  20 in total

Review 1.  The discovery and development of marine compounds with pharmaceutical potential.

Authors:  M H Munro; J W Blunt; E J Dumdei; S J Hickford; R E Lill; S Li; C N Battershill; A R Duckworth
Journal:  J Biotechnol       Date:  1999-04-30       Impact factor: 3.307

2.  Ecteinascidia turbinata extracts inhibit DNA synthesis in lymphocytes after mitogenic stimulation by lectins.

Authors:  W Lichter; D M Lopez; L L Wellham; M M Sigel
Journal:  Proc Soc Exp Biol Med       Date:  1975-11

Review 3.  How were new medicines discovered?

Authors:  David C Swinney; Jason Anthony
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

4.  Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

Authors:  H Luesch; R E Moore; V J Paul; S L Mooberry; T H Corbett
Journal:  J Nat Prod       Date:  2001-07       Impact factor: 4.050

Review 5.  The odyssey of marine pharmaceuticals: a current pipeline perspective.

Authors:  Alejandro M S Mayer; Keith B Glaser; Carmen Cuevas; Robert S Jacobs; William Kem; R Daniel Little; J Michael McIntosh; David J Newman; Barbara C Potts; Dale E Shuster
Journal:  Trends Pharmacol Sci       Date:  2010-04-02       Impact factor: 14.819

Review 6.  Systems genetics for drug target discovery.

Authors:  Nadia M Penrod; Richard Cowper-Sal-lari; Jason H Moore
Journal:  Trends Pharmacol Sci       Date:  2011-08-19       Impact factor: 14.819

7.  Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743.

Authors:  Christopher M Rath; Benjamin Janto; Josh Earl; Azad Ahmed; Fen Z Hu; Luisa Hiller; Meg Dahlgren; Rachael Kreft; Fengan Yu; Jeremy J Wolff; Hye Kyong Kweon; Michael A Christiansen; Kristina Håkansson; Robert M Williams; Garth D Ehrlich; David H Sherman
Journal:  ACS Chem Biol       Date:  2011-09-20       Impact factor: 5.100

8.  Crystal structures of Salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of beta-lactone ring opening and a mechanism for irreversible binding.

Authors:  Michael Groll; Robert Huber; Barbara C M Potts
Journal:  J Am Chem Soc       Date:  2006-04-19       Impact factor: 15.419

Review 9.  Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials.

Authors:  B C Potts; M X Albitar; K C Anderson; S Baritaki; C Berkers; B Bonavida; J Chandra; D Chauhan; J C Cusack; W Fenical; I M Ghobrial; M Groll; P R Jensen; K S Lam; G K Lloyd; W McBride; D J McConkey; C P Miller; S T C Neuteboom; Y Oki; H Ovaa; F Pajonk; P G Richardson; A M Roccaro; C M Sloss; M A Spear; E Valashi; A Younes; M A Palladino
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

10.  Cloning and characterization of an environmental DNA-derived gene cluster that encodes the biosynthesis of the antitumor substance BE-54017.

Authors:  Fang-Yuan Chang; Sean F Brady
Journal:  J Am Chem Soc       Date:  2011-05-04       Impact factor: 15.419

View more
  30 in total

Review 1.  Mass spectrometry tools and workflows for revealing microbial chemistry.

Authors:  Tal Luzzatto-Knaan; Alexey V Melnik; Pieter C Dorrestein
Journal:  Analyst       Date:  2015-08-07       Impact factor: 4.616

2.  Enhanced production of questin by marine-derived Aspergillus flavipes HN4-13.

Authors:  Lei Guo; Le Wang; Xiangrong Li; Xiaowen Xu; Jiacai Guo; Xintong Wang; Weiqin Yang; Fuxuan Xu; Fuhou Li
Journal:  3 Biotech       Date:  2020-01-21       Impact factor: 2.406

3.  Total Synthesis and Structural Reassignment of Lyngbyaloside C Highlighted by Intermolecular Ketene Esterification.

Authors:  Chia-Fu Chang; Eric Stefan; Richard E Taylor
Journal:  Chemistry       Date:  2015-06-23       Impact factor: 5.236

4.  The influence of sigma factors and ribosomal recognition elements on heterologous expression of cyanobacterial gene clusters in Escherichia coli.

Authors:  Kaitlyn N Wells; Patrick Videau; Dylan Nelson; Jessie E Eiting; Benjamin Philmus
Journal:  FEMS Microbiol Lett       Date:  2018-08-01       Impact factor: 2.742

Review 5.  Priorities for ocean microbiome research.

Authors: 
Journal:  Nat Microbiol       Date:  2022-06-30       Impact factor: 30.964

Review 6.  Marine Cyclic Peptides: Antimicrobial Activity and Synthetic Strategies.

Authors:  Ricardo Ribeiro; Eugénia Pinto; Carla Fernandes; Emília Sousa
Journal:  Mar Drugs       Date:  2022-06-15       Impact factor: 6.085

7.  The bromotyrosine derivative ianthelline isolated from the arctic marine sponge Stryphnus fortis inhibits marine micro- and macrobiofouling.

Authors:  Kine O Hanssen; Gunnar Cervin; Rozenn Trepos; Julie Petitbois; Tor Haug; Espen Hansen; Jeanette H Andersen; Henrik Pavia; Claire Hellio; Johan Svenson
Journal:  Mar Biotechnol (NY)       Date:  2014-07-23       Impact factor: 3.619

8.  Structural Basis for Cyclopropanation by a Unique Enoyl-Acyl Carrier Protein Reductase.

Authors:  Dheeraj Khare; Wendi A Hale; Ashootosh Tripathi; Liangcai Gu; David H Sherman; William H Gerwick; Kristina Håkansson; Janet L Smith
Journal:  Structure       Date:  2015-10-29       Impact factor: 5.006

Review 9.  Spirotetronate polyketides as leads in drug discovery.

Authors:  Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  J Nat Prod       Date:  2014-12-01       Impact factor: 4.050

10.  Discovery of potent broad spectrum antivirals derived from marine actinobacteria.

Authors:  Avi Raveh; Phillip C Delekta; Craig J Dobry; Weiping Peng; Pamela J Schultz; Pennelope K Blakely; Andrew W Tai; Teatulohi Matainaho; David N Irani; David H Sherman; David J Miller
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.